Nuvation Bio's market cap is currently $1.11B. The company's EPS TTM is $-0.17; its P/E ratio is ―; Nuvation Bio is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
